Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2005-2-7
pubmed:abstractText
Maurocalcine is a scorpion venom toxin of 33 residues that bears a striking resemblance to the domain A of the dihydropyridine voltage-dependent calcium channel type 1.1 (Cav1.1) subunit. This domain belongs to the II-III loop of Cav1.1, which is implicated in excitation-contraction coupling. Besides the structural homology, maurocalcine also modulates RyR1 channel activity in a manner akin to a synthetic peptide of domain A. Because of these similarities, we hypothesized that maurocalcine and domain A may bind onto an identical region(s) of RyR1. Using a set of RyR1 fragments, we demonstrate that peptide A and maurocalcine bind onto two discrete RyR1 regions: fragments 3 and 7 encompassing residues 1021-1631 and 3201-3661, respectively. The binding onto fragment 7 is of greater importance and was thus further investigated. We found that the amino acid region 3351-3507 of RyR1 (fragment 7.2) is sufficient for these interactions. Proof that peptide A and maurocalcine bind onto the same site is provided by competition experiments in which binding of fragment 7.2 to peptide A is inhibited by preincubation with maurocalcine. Moreover, when expressed in COS-7 cells, RyR1 carrying a deletion of fragment 7 shows a loss of interaction with both peptide A and maurocalcine. At the functional level, this deletion abolishes the maurocalcine induced stimulation of [3H]ryanodine binding onto microsomes of transfected COS-7 cells without affecting the caffeine and ATP responses.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15591063-10075681, http://linkedlifedata.com/resource/pubmed/commentcorrection/15591063-10713267, http://linkedlifedata.com/resource/pubmed/commentcorrection/15591063-10861934, http://linkedlifedata.com/resource/pubmed/commentcorrection/15591063-11751303, http://linkedlifedata.com/resource/pubmed/commentcorrection/15591063-12045016, http://linkedlifedata.com/resource/pubmed/commentcorrection/15591063-12429019, http://linkedlifedata.com/resource/pubmed/commentcorrection/15591063-12496092, http://linkedlifedata.com/resource/pubmed/commentcorrection/15591063-1249731, http://linkedlifedata.com/resource/pubmed/commentcorrection/15591063-12586831, http://linkedlifedata.com/resource/pubmed/commentcorrection/15591063-12869557, http://linkedlifedata.com/resource/pubmed/commentcorrection/15591063-12900411, http://linkedlifedata.com/resource/pubmed/commentcorrection/15591063-14535845, http://linkedlifedata.com/resource/pubmed/commentcorrection/15591063-1654596, http://linkedlifedata.com/resource/pubmed/commentcorrection/15591063-2165570, http://linkedlifedata.com/resource/pubmed/commentcorrection/15591063-2448641, http://linkedlifedata.com/resource/pubmed/commentcorrection/15591063-7673188, http://linkedlifedata.com/resource/pubmed/commentcorrection/15591063-8134386, http://linkedlifedata.com/resource/pubmed/commentcorrection/15591063-8598910, http://linkedlifedata.com/resource/pubmed/commentcorrection/15591063-8751443, http://linkedlifedata.com/resource/pubmed/commentcorrection/15591063-9176137, http://linkedlifedata.com/resource/pubmed/commentcorrection/15591063-9358051, http://linkedlifedata.com/resource/pubmed/commentcorrection/15591063-9593671, http://linkedlifedata.com/resource/pubmed/commentcorrection/15591063-9737952, http://linkedlifedata.com/resource/pubmed/commentcorrection/15591063-9792715, http://linkedlifedata.com/resource/pubmed/commentcorrection/15591063-9895277
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
11
pubmed:volume
280
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4013-6
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:15591063-Adenosine Triphosphate, pubmed-meshheading:15591063-Animals, pubmed-meshheading:15591063-Binding, Competitive, pubmed-meshheading:15591063-Binding Sites, pubmed-meshheading:15591063-COS Cells, pubmed-meshheading:15591063-Calcium Channels, L-Type, pubmed-meshheading:15591063-Caveolin 1, pubmed-meshheading:15591063-Caveolins, pubmed-meshheading:15591063-Chromatography, pubmed-meshheading:15591063-Cloning, Molecular, pubmed-meshheading:15591063-Cryoelectron Microscopy, pubmed-meshheading:15591063-Microscopy, Fluorescence, pubmed-meshheading:15591063-Muscle, Skeletal, pubmed-meshheading:15591063-Peptides, pubmed-meshheading:15591063-Plasmids, pubmed-meshheading:15591063-Protein Binding, pubmed-meshheading:15591063-Protein Structure, Tertiary, pubmed-meshheading:15591063-Recombinant Fusion Proteins, pubmed-meshheading:15591063-Ryanodine, pubmed-meshheading:15591063-Ryanodine Receptor Calcium Release Channel, pubmed-meshheading:15591063-Scorpion Venoms, pubmed-meshheading:15591063-Transfection
pubmed:year
2005
pubmed:articleTitle
Maurocalcine and domain A of the II-III loop of the dihydropyridine receptor Cav 1.1 subunit share common binding sites on the skeletal ryanodine receptor.
pubmed:affiliation
INSERM U607/DRDC, CEA, 17 rue des Martyrs, 38054 Grenoble Cedex 09, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't